Crinetics Pharmaceuticals CRNX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 46.55 | 992 | -11.90 | -123 | -10.58 | 1,126 |
| 2025Q3 | 41.65 | 1,072 | -11.60 | -130 | -10.47 | 1,196 |
| 2025Q2 | 28.76 | 1,172 | -9.54 | -116 | -8.72 | 1,290 |
| 2025Q1 | 33.54 | 1,254 | -7.51 | -97 | -6.92 | 1,361 |
| 2024Q4 | 51.13 | 1,325 | -7.47 | -81 | -6.80 | 1,435 |
| 2024Q3 | 51.10 | 833 | -9.24 | -77 | -8.20 | 937 |
| 2024Q2 | 44.79 | 831 | -8.68 | -74 | -7.74 | 936 |
| 2024Q1 | 46.81 | 875 | -9.47 | -67 | -8.30 | 978 |
| 2023Q4 | 35.58 | 539 | -11.06 | -60 | -9.41 | 635 |
| 2023Q3 | 29.74 | 548 | -14.33 | -57 | -12.29 | 642 |
| 2023Q2 | 18.02 | 254 | -19.08 | -51 | -16.79 | 293 |
| 2023Q1 | 16.06 | 280 | -15.42 | -46 | -13.81 | 314 |
| 2022Q4 | 18.30 | 316 | -13.48 | -45 | -12.21 | 352 |
| 2022Q3 | 19.64 | 351 | -11.37 | -42 | -10.40 | 385 |
| 2022Q2 | 18.65 | 386 | -12.30 | -42 | -11.22 | 422 |
| 2022Q1 | 21.95 | 303 | -10.91 | -35 | -10.12 | 333 |
| 2021Q4 | 28.41 | 332 | -11.72 | -31 | -10.99 | 351 |
| 2021Q3 | 21.05 | 194 | -14.10 | -28 | -13.07 | 209 |
| 2021Q2 | 18.85 | 201 | -14.87 | -26 | -13.72 | 217 |
| 2021Q1 | 15.28 | 149 | -14.39 | -23 | -13.20 | 164 |